Histone variant H2A.Z can serve as a new target for breast cancer therapy

D. Rangasamy*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    35 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Histone variant H2A.Z can serve as a new target for breast cancer therapy'. Together they form a unique fingerprint.

    Biochemistry, Genetics and Molecular Biology